{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T22:19:39Z","timestamp":1779229179513,"version":"3.51.4"},"reference-count":46,"publisher":"American Association for Cancer Research (AACR)","issue":"9","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Previous studies suggest that carotenoids and tocopherols (vitamin E compounds) may be inversely associated with prostate cancer risk, yet little is known about how they affect prostate cancer progression and survival. We investigated whether serum \u03b1-tocopherol, \u03b2-carotene, and retinol concentrations, or the \u03b1-tocopherol and \u03b2-carotene trial supplementation, affected survival of men diagnosed with prostate cancer during the \u03b1-Tocopherol, \u03b2-Carotene Cancer Prevention Study, a randomized, double-blind, placebo-controlled primary prevention trial testing the effects of \u03b2-carotene and \u03b1-tocopherol supplements on cancer incidence in adult male smokers in southwestern Finland (n = 29,133). Prostate cancer survival was examined using the Kaplan-Meier method with deaths from other causes treated as censoring, and using Cox proportional hazards regression models with hazard ratios (HR) and 95% confidence intervals (CI) adjusted for family history of prostate cancer, age at randomization, benign prostatic hyperplasia, age and stage at diagnosis, height, body mass index, and serum cholesterol. As of April 2005, 1,891 men were diagnosed with prostate cancer and 395 died of their disease. Higher serum \u03b1-tocopherol at baseline was associated with improved prostate cancer survival (HR, 0.67; 95% CI, 0.45\u20131.00), especially among cases who had received the \u03b1-tocopherol intervention of the trial and who were in the highest quintile of \u03b1-tocopherol at baseline (HR, 0.51; 95% CI, 0.20\u20130.90) or at the 3-year follow-up measurement (HR, 0.26; 95% CI, 0.09\u20130.71). Serum \u03b2-carotene, serum retinol, and supplemental \u03b2-carotene had no apparent effects on survival. These findings suggest that higher \u03b1-tocopherol (and not \u03b2-carotene or retinol) status increases overall prostate cancer survival. Further investigations, possibly including randomized studies, are needed to confirm this observation. [Cancer Res 2009;69(9):3833\u201341]<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-4640","type":"journal-article","created":{"date-parts":[[2009,4,22]],"date-time":"2009-04-22T03:00:39Z","timestamp":1240369239000},"page":"3833-3841","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Associations between \u03b1-Tocopherol, \u03b2-Carotene, and Retinol and Prostate Cancer Survival"],"prefix":"10.1158","volume":"69","author":[{"given":"Joanne L.","family":"Watters","sequence":"first","affiliation":[{"name":"1Nutritional Epidemiology Branch and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell H.","family":"Gail","sequence":"additional","affiliation":[{"name":"2Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, Maryland; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie J.","family":"Weinstein","sequence":"additional","affiliation":[{"name":"1Nutritional Epidemiology Branch and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarmo","family":"Virtamo","sequence":"additional","affiliation":[{"name":"3Department of Health Promotion and Chronic Disease Prevention, National Public Health Institute, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demetrius","family":"Albanes","sequence":"additional","affiliation":[{"name":"1Nutritional Epidemiology Branch and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2009,4,30]]},"reference":[{"key":"2022061701490360600_B1","doi-asserted-by":"crossref","unstructured":"Jemal A, Siegel R, Ward E, et al. Cancer Statistics, 2008. CA Cancer J Clin\u20082008; 58: 71\u201396.","DOI":"10.3322\/CA.2007.0010"},{"key":"2022061701490360600_B2","unstructured":"Signorello LB, Adami H-O. Prostate Cancer. In: Adami H-O, Hunter D, Trichopoulos D, editors. Textbook of Cancer Epidemiology. Oxford: Oxford University Press; 2002."},{"key":"2022061701490360600_B3","doi-asserted-by":"crossref","unstructured":"Sequoia JSP, Wright ME, McCarron P, et al. A prospective investigation of height and prostate cancer risk. Cancer Epidemiol Biomarkers Prev\u20082006; 15: 2174\u20138.","DOI":"10.1158\/1055-9965.EPI-06-0467"},{"key":"2022061701490360600_B4","doi-asserted-by":"crossref","unstructured":"Montgomery RB, Goldman B, Tangen CM, et al. Association of body mass index with response and survival in men with metastatic prostate cancer: Southwest Oncology Group Trials 8894 and 9916. J Urol\u20082007; 178: 1946\u201351.","DOI":"10.1016\/j.juro.2007.07.026"},{"key":"2022061701490360600_B5","doi-asserted-by":"crossref","unstructured":"Shimizu H, Ross R, Bernstein L, et al. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer\u20081991; 63: 963\u20136.","DOI":"10.1038\/bjc.1991.210"},{"key":"2022061701490360600_B6","unstructured":"Ries L, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975\u20132004. Bethesda (MD): National Cancer Institute; 2007."},{"key":"2022061701490360600_B7","doi-asserted-by":"crossref","unstructured":"Wright ME, Weinstein SJ, Lawson KA, et al. Supplemental and dietary vitamin e intakes and risk of prostate cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev\u20082007; 16: 1128\u201335.","DOI":"10.1158\/1055-9965.EPI-06-1071"},{"key":"2022061701490360600_B8","doi-asserted-by":"crossref","unstructured":"Weinstein SJ, Wright ME, Lawson KA, et al. Serum and dietary vitamin e in relation to prostate cancer risk. Cancer Epidemiol Biomarkers Prev\u20082007; 16: 1253\u20139.","DOI":"10.1158\/1055-9965.EPI-06-1084"},{"key":"2022061701490360600_B9","doi-asserted-by":"crossref","unstructured":"Key TJ, Appleby PN, Allen NE, et al. Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study. Am J Clin Nutr\u20082007; 86: 672\u201381.","DOI":"10.1093\/ajcn\/86.3.672"},{"key":"2022061701490360600_B10","doi-asserted-by":"crossref","unstructured":"Kirsh VA, Hayes RB, Mayne ST, et al. Supplemental and dietary vitamin e, \u03b2-carotene, and vitamin c intakes and prostate cancer risk. J Natl Cancer Inst\u20082006; 98: 245\u201354.","DOI":"10.1093\/jnci\/djj050"},{"key":"2022061701490360600_B11","doi-asserted-by":"crossref","unstructured":"Kenfield S, Chang S, Chan J. Diet and lifestyle interventions in active surveillance patients with favorable-risk prostate cancer. Curr Treat Options Oncol\u20082007; 8: 173\u201396.","DOI":"10.1007\/s11864-007-0034-0"},{"key":"2022061701490360600_B12","doi-asserted-by":"crossref","unstructured":"Demark-Wahnefried W, Moyad MA. Dietary intervention in the management of prostate cancer. Curr Opin Urol\u20082007; 17: 168\u201374.","DOI":"10.1097\/MOU.0b013e3280eb10fc"},{"key":"2022061701490360600_B13","doi-asserted-by":"crossref","unstructured":"Berkow SE, Barnard ND, Saxe GA, Ankerberg-Nobis T. Diet and survival after prostate cancer diagnosis. Nutr Rev\u20082007; 65: 391\u2013403.","DOI":"10.1111\/j.1753-4887.2007.tb00317.x"},{"key":"2022061701490360600_B14","doi-asserted-by":"crossref","unstructured":"Chan J, Holick C, Leitzmann M, et al. Diet after diagnosis and the risk of prostate cancer progression, recurrence, and death (United States). Cancer Causes Control\u20082006; 17: 199\u2013208.","DOI":"10.1007\/s10552-005-0413-4"},{"key":"2022061701490360600_B15","unstructured":"National Academy of Sciences (NAS) IoM. Dietary References Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids: A Report of the Panel on Dietary Antioxidants and Related Compounds, Subcommittees on Upper Reference Levels of Nutrients and on Interpretation and Use of Dietary Reference Intakes, and the Standing Committee on Scientific Evaluation of Dietary Reference Intakes. Washington (DC): National Academy Press; 2001."},{"key":"2022061701490360600_B16","unstructured":"Omenn G. Micronutrients (vitamins and minerals) as cancer-preventive agents. IARC Sci Publ\u20081996; 139: 33\u201345."},{"key":"2022061701490360600_B17","doi-asserted-by":"crossref","unstructured":"The \u03b1-Tocophero \u03b2 Carotene Cancer Prevention Study Group. The effect of vitamin E and \u03b2 carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med\u20081994; 330: 1029\u201335.","DOI":"10.1056\/NEJM199404143301501"},{"key":"2022061701490360600_B18","doi-asserted-by":"crossref","unstructured":"Korhonen P, Malila N, Pukkala E, et al. The Finnish Cancer Registry as follow-up source of a large trial cohort-accuracy and delay. Acta Oncol\u20082002; 41: 381\u20138.","DOI":"10.1080\/028418602760169442"},{"key":"2022061701490360600_B19","unstructured":"American Joint Committee on Cancer. Manual for staging of cancer. Philadelphia: J.B. Lippincott Company; 1992."},{"key":"2022061701490360600_B20","doi-asserted-by":"crossref","unstructured":"Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with \u03b1-tocopherol and \u03b2-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst\u20081998; 90: 440\u20136.","DOI":"10.1093\/jnci\/90.6.440"},{"key":"2022061701490360600_B21","doi-asserted-by":"crossref","unstructured":"The ATBC Cancer Prevention Study Group. The \u03b1-tocopherol, \u03b2-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. Ann Epidemiol\u20081994; 4: 1\u201310.","DOI":"10.1016\/1047-2797(94)90036-1"},{"key":"2022061701490360600_B22","doi-asserted-by":"crossref","unstructured":"Milne DB, Botnen J. Retinol, \u03b1-tocopherol, lycopene, and \u03b1- and \u03b2-carotene simultaneously determined in plasma by isocratic liquid chromatography. Clin Chem\u20081986; 32: 874\u20136.","DOI":"10.1093\/clinchem\/32.5.874"},{"key":"2022061701490360600_B23","doi-asserted-by":"crossref","unstructured":"Kattermann R, Jaworek D, Mo\u0308ller G, et al. Multicentre study of a new enzymatic method of cholesterol determination. J Clin Chem Clin Biochem\u20081984; 22: 245\u201351.","DOI":"10.1515\/cclm.1984.22.3.245"},{"key":"2022061701490360600_B24","doi-asserted-by":"crossref","unstructured":"Willett WC. Nutritional epidemiology. New York (NY): Oxford University Press; 1998.","DOI":"10.1093\/acprof:oso\/9780195122978.001.0001"},{"key":"2022061701490360600_B25","doi-asserted-by":"crossref","unstructured":"The ATBC Study Group. Incidence of cancer and mortality following {\u03b1}-tocopherol and {\u03b2}-carotene supplementation: a postintervention follow-up. JAMA\u20082003; 290: 476\u201385.","DOI":"10.1001\/jama.290.4.476"},{"key":"2022061701490360600_B26","doi-asserted-by":"crossref","unstructured":"Gaziano JM, Glynn RJ, Christen WG, et al. Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II Randomized Controlled Trial. JAMA\u20082009; 301: 52\u201362.","DOI":"10.1001\/jama.2008.862"},{"key":"2022061701490360600_B27","doi-asserted-by":"crossref","unstructured":"Lippman SM, Klein EA, Goodman PJ, et al. Effect of Selenium and vitamin E on Risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA\u20082009; 301: 39\u201351.","DOI":"10.1001\/jama.2009.627"},{"key":"2022061701490360600_B28","doi-asserted-by":"crossref","unstructured":"Gogos CA, Ginopoulos P, Salsa B, et al. Dietary \u03c9-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy. Cancer\u20081998; 82: 395\u2013402.","DOI":"10.1002\/(SICI)1097-0142(19980115)82:2<403::AID-CNCR21>3.0.CO;2-1"},{"key":"2022061701490360600_B29","doi-asserted-by":"crossref","unstructured":"Ornish D, Weidner G, Fair WR, et al. Intensive lifestyle changes may affect the progression of prostate cancer. J Urol\u20082005; 174: 1065\u201370.","DOI":"10.1097\/01.ju.0000169487.49018.73"},{"key":"2022061701490360600_B30","doi-asserted-by":"crossref","unstructured":"Bjelakovic G, Nikolova D, Gluud L, Simonetti R, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev\u20082008; 16: CD007176.","DOI":"10.1002\/14651858.CD007176"},{"key":"2022061701490360600_B31","doi-asserted-by":"crossref","unstructured":"Wright ME, Lawson KA, Weinstein SJ, et al. Higher baseline serum concentrations of vitamin E are associated with lower total and cause-specific mortality in the \u03b1-Tocopherol, \u03b2-Carotene Cancer Prevention Study. Am J Clin Nutr\u20082006; 84: 1200\u20137.","DOI":"10.1093\/ajcn\/84.5.1200"},{"key":"2022061701490360600_B32","doi-asserted-by":"crossref","unstructured":"Chan JM, Gann PH, Giovannucci EL. Role of diet in prostate cancer development and progression. J Clin Oncol\u20082005; 23: 8152\u201360.","DOI":"10.1200\/JCO.2005.03.1492"},{"key":"2022061701490360600_B33","doi-asserted-by":"crossref","unstructured":"Venkateswaran V, Fleshner N, Klotz L. Modulation of cell proliferation and cell cycle regulators by vitamin E in human prostate carcinoma cell lines. J Urol\u20082002; 168: 1578\u201382.","DOI":"10.1097\/00005392-200210010-00088"},{"key":"2022061701490360600_B34","doi-asserted-by":"crossref","unstructured":"Ni J, Wen X, Yao J, et al. Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway. Cancer Res\u20082005; 65: 9807\u201316.","DOI":"10.1158\/0008-5472.CAN-05-1334"},{"key":"2022061701490360600_B35","doi-asserted-by":"crossref","unstructured":"Crispen PL, Uzzo RG, Golovine K, et al. Vitamin E succinate inhibits NF-\u03baB and prevents the development of a metastatic phenotype in prostate cancer cells:implications for chemoprevention. Prostate\u20082007; 67: 582\u201390.","DOI":"10.1002\/pros.20468"},{"key":"2022061701490360600_B36","doi-asserted-by":"crossref","unstructured":"Hartman TJ, Dorgan JF, Woodson K, et al. Effects of long-term \u03b1-tocopherol supplementation on serum hormones in older men. Prostate\u20082001; 46: 33\u20138.","DOI":"10.1002\/1097-0045(200101)46:1<33::AID-PROS1005>3.0.CO;2-6"},{"key":"2022061701490360600_B37","doi-asserted-by":"crossref","unstructured":"Peters U, Littman AJ, Kristal AR, et al. Vitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and lifestyle (VITAL) study cohort. Cancer Causes Control\u20082008; 19: 75\u201387.","DOI":"10.1007\/s10552-007-9072-y"},{"key":"2022061701490360600_B38","doi-asserted-by":"crossref","unstructured":"Lonn E, Bosch J, Yusuf S, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a Randomized Controlled Trial. JAMA\u20082005; 293: 1338\u201347.","DOI":"10.1001\/jama.293.11.1338"},{"key":"2022061701490360600_B39","doi-asserted-by":"crossref","unstructured":"Lawson KA, Wright ME, Subar A, et al. Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study. J Natl Cancer Inst\u20082007; 99: 754\u201364.","DOI":"10.1093\/jnci\/djk177"},{"key":"2022061701490360600_B40","doi-asserted-by":"crossref","unstructured":"Satia-Abouta J, Patterson RE, King IB, et al. Reliability and validity of self-report of vitamin and mineral supplement use in the Vitamins and Lifestyle Study. Am J Epidemiol\u20082003; 157: 944\u201354.","DOI":"10.1093\/aje\/kwg039"},{"key":"2022061701490360600_B41","doi-asserted-by":"crossref","unstructured":"Li H, Kantoff PW, Giovannucci E, et al. Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. Cancer Res\u20082005; 65: 2498\u2013504.","DOI":"10.1158\/0008-5472.CAN-04-3535"},{"key":"2022061701490360600_B42","unstructured":"van Gils CH, Bostick RM, Stern MC, Taylor JA. Differences in base excision repair capacity may modulate the effect of dietary antioxidant intake on prostate cancer risk: an example of polymorphisms in the XRCC1 gene. Cancer Epidemiol Biomarkers Prev\u20082002; 11: 1279\u201384."},{"key":"2022061701490360600_B43","unstructured":"Woodson K, Tangrea JA, Lehman TA, et al. Manganese superoxide dismutase (MnSOD) polymorphism, \u03b1-tocopherol supplementation and prostate cancer risk in the \u03b1-Tocopherol, \u03b2-Carotene Cancer Prevention Study (Finland). Cancer Causes Control\u20082003; 14: 513\u20138."},{"key":"2022061701490360600_B44","unstructured":"Goodman GE, Schaffer S, Omenn GS, Chen C, King I. The association between lung and prostate cancer risk, and serum micronutrients: results and Lessons learned from \u03b2-Carotene and Retinol Efficacy Trial. Cancer Epidemiol Biomarkers Prev\u20082003; 12: 518\u201326."},{"key":"2022061701490360600_B45","doi-asserted-by":"crossref","unstructured":"Cook N, Le I, Manson J, Buring J, Hennekens C. Effects of \u03b2-carotene supplementation on cancer incidence by baseline characteristics in the Physicians' Health Study (United States). Cancer Causes Control\u20082000; 11: 617\u201326.","DOI":"10.1023\/A:1008995430664"},{"key":"2022061701490360600_B46","doi-asserted-by":"crossref","unstructured":"Peters U, Leitzmann MF, Chatterjee N, et al. Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev\u20082007; 16: 962\u20138.","DOI":"10.1158\/1055-9965.EPI-06-0861"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/9\/3833\/2623996\/3833.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/9\/3833\/2623996\/3833.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T09:21:18Z","timestamp":1655457678000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/69\/9\/3833\/553342\/Associations-between-Tocopherol-Carotene-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,30]]},"references-count":46,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2009,4,30]]},"published-print":{"date-parts":[[2009,5,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-4640","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,30]]}}}